Finally a breakthrough with postpartum depression.

Women’s health issues frequently take a backseat to male conditions.

Erectile dysfunction research has beat off breast cancer, migraines, uterine cancer and yes, postpartum depression for decades.

The US Food and Drug Administration has just approved the medication, Zurzuvae, for the treatment of postpartum depression making it the first FDA approved oral pill in the United States specifically for postpartum depression.

Postpartum depression is a serious mental illness that can develop in 1 in 7 new mothers after childbirth.

Potentially a life-threatening condition, women often experience sadness, guilt, worthlessness and, even in severe cases, thoughts of harming themselves or their child.

This condition can disrupt the maternal-infant bond, having consequences for the child’s physical and emotional development.

Family members and employers often judge women harshly, inaccurately thinking women are exaggerating their feelings.

I remember how different I felt physically two days after giving birth. My hormones were raging, my migraines which had abated while I was pregnant, returned with avengeance literally knocking me to the floor.

I was fortunate that I had established my own public relations firm and needed to go back to work immediately not having the time to analyze all my feelings. I just plowed ahead and luckily for me, I was emotionally grounded.

I was able to work through the physical changes I was experiencing and spend quality time with my newborn daughter, bonding with her soon after the birth.

I established a home office and successfully balanced being a mother who was always there for my daughter and still maintain a thriving business.

This pill is an amazing breakthrough for women and can potentially remove all the shame, guilt and judgment associated with a very real physical condition often underdiagnosed and undertreated.

Thankfully, we have finally come a long way, baby.